State of the art management in spine oncology: a worldwide perspective on its evolution, current state, and future.

Narayan Sundaresan, Stefano Boriani, Scott Okuno

Research output: Contribution to journalArticle

Abstract

STUDY DESIGN: A review of the past and current status of the evolving field of spine oncology. OBJECTIVE: To provide a framework of reference for developments in the field, particularly the rapidly evolving field of molecular biology, as well as contemporary practice in the management of spine tumors. METHODS: Literature review of the surgical treatment of spine tumors in the past and present, the emerging radiologic and biologic technologies, as well as the field of targeted therapy in cancer and the economic implications of technological advances. RESULTS: A vast contemporary literature is currently available that provides a clear rational basis for treatment. Most treatment recommendations are currently based on retrospective data and small Phase II prospective studies. Treatment paradigms continue to evolve without their relative merits being evaluated by randomized controlled trials. The current lack of randomized trials in spine oncology reflect both the rarity of spine tumors and strongly held biases based on retrospective studies and institutional bias. CONCLUSION: Spine oncology is a rapidly evolving field with contributions in surgery, radiation therapy, and targeted chemotherapy resulting in overall improvement in quality of life and survival in patients with spine tumors. However, the economic consequences of these improvements are substantial and need to be kept in proper perspective.

Original languageEnglish
JournalSpine
Volume34
Issue number22 Suppl
Publication statusPublished - Oct 15 2009

Fingerprint

Spine
Neoplasms
Radiologic Technology
Economics
Literature
Therapeutics
Practice Management
Molecular Biology
Radiotherapy
Randomized Controlled Trials
Retrospective Studies
Quality of Life
Prospective Studies
Drug Therapy
Survival

ASJC Scopus subject areas

  • Clinical Neurology
  • Orthopedics and Sports Medicine

Cite this

State of the art management in spine oncology : a worldwide perspective on its evolution, current state, and future. / Sundaresan, Narayan; Boriani, Stefano; Okuno, Scott.

In: Spine, Vol. 34, No. 22 Suppl, 15.10.2009.

Research output: Contribution to journalArticle

Sundaresan, Narayan ; Boriani, Stefano ; Okuno, Scott. / State of the art management in spine oncology : a worldwide perspective on its evolution, current state, and future. In: Spine. 2009 ; Vol. 34, No. 22 Suppl.
@article{e35affa627f84e7bbf34a1ac0e9c132b,
title = "State of the art management in spine oncology: a worldwide perspective on its evolution, current state, and future.",
abstract = "STUDY DESIGN: A review of the past and current status of the evolving field of spine oncology. OBJECTIVE: To provide a framework of reference for developments in the field, particularly the rapidly evolving field of molecular biology, as well as contemporary practice in the management of spine tumors. METHODS: Literature review of the surgical treatment of spine tumors in the past and present, the emerging radiologic and biologic technologies, as well as the field of targeted therapy in cancer and the economic implications of technological advances. RESULTS: A vast contemporary literature is currently available that provides a clear rational basis for treatment. Most treatment recommendations are currently based on retrospective data and small Phase II prospective studies. Treatment paradigms continue to evolve without their relative merits being evaluated by randomized controlled trials. The current lack of randomized trials in spine oncology reflect both the rarity of spine tumors and strongly held biases based on retrospective studies and institutional bias. CONCLUSION: Spine oncology is a rapidly evolving field with contributions in surgery, radiation therapy, and targeted chemotherapy resulting in overall improvement in quality of life and survival in patients with spine tumors. However, the economic consequences of these improvements are substantial and need to be kept in proper perspective.",
author = "Narayan Sundaresan and Stefano Boriani and Scott Okuno",
year = "2009",
month = "10",
day = "15",
language = "English",
volume = "34",
journal = "Spine",
issn = "0362-2436",
publisher = "Lippincott Williams and Wilkins",
number = "22 Suppl",

}

TY - JOUR

T1 - State of the art management in spine oncology

T2 - a worldwide perspective on its evolution, current state, and future.

AU - Sundaresan, Narayan

AU - Boriani, Stefano

AU - Okuno, Scott

PY - 2009/10/15

Y1 - 2009/10/15

N2 - STUDY DESIGN: A review of the past and current status of the evolving field of spine oncology. OBJECTIVE: To provide a framework of reference for developments in the field, particularly the rapidly evolving field of molecular biology, as well as contemporary practice in the management of spine tumors. METHODS: Literature review of the surgical treatment of spine tumors in the past and present, the emerging radiologic and biologic technologies, as well as the field of targeted therapy in cancer and the economic implications of technological advances. RESULTS: A vast contemporary literature is currently available that provides a clear rational basis for treatment. Most treatment recommendations are currently based on retrospective data and small Phase II prospective studies. Treatment paradigms continue to evolve without their relative merits being evaluated by randomized controlled trials. The current lack of randomized trials in spine oncology reflect both the rarity of spine tumors and strongly held biases based on retrospective studies and institutional bias. CONCLUSION: Spine oncology is a rapidly evolving field with contributions in surgery, radiation therapy, and targeted chemotherapy resulting in overall improvement in quality of life and survival in patients with spine tumors. However, the economic consequences of these improvements are substantial and need to be kept in proper perspective.

AB - STUDY DESIGN: A review of the past and current status of the evolving field of spine oncology. OBJECTIVE: To provide a framework of reference for developments in the field, particularly the rapidly evolving field of molecular biology, as well as contemporary practice in the management of spine tumors. METHODS: Literature review of the surgical treatment of spine tumors in the past and present, the emerging radiologic and biologic technologies, as well as the field of targeted therapy in cancer and the economic implications of technological advances. RESULTS: A vast contemporary literature is currently available that provides a clear rational basis for treatment. Most treatment recommendations are currently based on retrospective data and small Phase II prospective studies. Treatment paradigms continue to evolve without their relative merits being evaluated by randomized controlled trials. The current lack of randomized trials in spine oncology reflect both the rarity of spine tumors and strongly held biases based on retrospective studies and institutional bias. CONCLUSION: Spine oncology is a rapidly evolving field with contributions in surgery, radiation therapy, and targeted chemotherapy resulting in overall improvement in quality of life and survival in patients with spine tumors. However, the economic consequences of these improvements are substantial and need to be kept in proper perspective.

UR - http://www.scopus.com/inward/record.url?scp=75349088074&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=75349088074&partnerID=8YFLogxK

M3 - Article

C2 - 19816243

AN - SCOPUS:75349088074

VL - 34

JO - Spine

JF - Spine

SN - 0362-2436

IS - 22 Suppl

ER -